ENTRY       D09704                      Drug
NAME        Atacicept (USAN/INN)
FORMULA     C3104H4788N856O950S44
EXACT_MASS  70662.0376
MOL_WEIGHT  70707.2547
SEQUENCE    AMRSCPEEQY WDPLLGTCMS CKTICNHQSQ RTCAAFCRSL SCRKEQGKFY DHLLRDCISC
            ASICGQHPKQ CAYFCENKLR SEPKSSDKTH TCPPCPAPEA EGAPSVFLFP PKPKDTLMIS
            RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE QYNSTYRVVS VLTVLHQDWL
            NGKEYKCKVS NKALPSSIEK TISKAKGQPR EPQVYTLPPS RDELTKNQVS LTCLVKGFYP
            SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK SRWQQGNVFS CSVMHEALHN
            HYTQKSLSLS PGK
            (Disulfide bridge: 5-18, 21-33, 25-37, 42-57, 60-71, 64-75, 127-187, 233-291, 92-92', 95-95')
  TYPE      Peptide
EFFICACY    Immunosuppressant
COMMENT     fusion protein (TACI [HSA:23495] [KO:K05150] - Ig)
            Treatment of autoimmune disease
TARGET      TNFSF13 (APRIL, CD256) [HSA:8741] [KO:K05475]
            TNFSF13B (BAFF, CD257) [HSA:10673] [KO:K05476]
  PATHWAY   hsa04060(10673+8741)  Cytokine-cytokine receptor interaction
            hsa05323(10673+8741)  Rheumatoid arthritis
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNFSF13 (APRIL, CD256)
                 D09704  Atacicept (USAN/INN)
                TNFSF13B (BAFF, CD257)
                 D09704  Atacicept (USAN/INN)
DBLINKS     CAS: 845264-92-8
            PubChem: 124490444
///
